Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2026-03-13 @ 5:34 PM
Study NCT ID:
NCT00538395
Status:
UNKNOWN
Last Update Posted:
2011-12-13
First Post:
2007-10-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer
Sponsor:
King Faisal Specialist Hospital & Research Center
Organization:
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2011-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Intensive sequential chemotherapy with Adriamycin Taxol and Cytoxan in the treatment of locally advanced breast cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: